Cite
Fludarabine in the treatment of chronic lymphocytic leukemia: a review.
MLA
Ricci, Francesca, et al. “Fludarabine in the Treatment of Chronic Lymphocytic Leukemia: A Review.” Therapeutics & Clinical Risk Management, vol. 5, Jan. 2009, pp. 187–207. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=84983983&authtype=sso&custid=ns315887.
APA
Ricci, F., Tedeschi, A., Morra, E., & Montillo, M. (2009). Fludarabine in the treatment of chronic lymphocytic leukemia: a review. Therapeutics & Clinical Risk Management, 5, 187–207.
Chicago
Ricci, Francesca, Alessandra Tedeschi, Enrica Morra, and Marco Montillo. 2009. “Fludarabine in the Treatment of Chronic Lymphocytic Leukemia: A Review.” Therapeutics & Clinical Risk Management 5 (January): 187–207. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=84983983&authtype=sso&custid=ns315887.